Skip to content
‹ Back to IndustriesSciences

7 Companies Bringing Innovation to NRF 2019

It’s possible that no group of companies benefits as much from NRF 2019 as those with space in the Innovation Lab. Designed to group start-ups together in an easy to navigate area, the Innovation Lab is a carefully curated group of businesses that the NRF believes have something significant to show off. MarketScale took a…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Geoff Short · · Geoff Short Article
Share
7 Companies Bringing Innovation to NRF 2019

Key takeaways

01

It’s possible that no group of companies benefits as much from NRF 2019 as those with space in the Innovation Lab.

02

Designed to group start-ups together in an easy to navigate area, the Innovation Lab is a carefully curated group of businesses that the NRF believes have something significant to show off.

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

It’s possible that no group of companies benefits as much from NRF 2019 as those with space in the Innovation Lab. Designed to group start-ups together in an easy to navigate area, the Innovation Lab is a carefully curated group of businesses that the NRF believes have something significant to show off.

MarketScale took a private media tour of the area on the first day of NRF 2019 to see what stood out amongst these rising brands.

Perfitly: More and more, shoppers have turned to the internet to purchase products because of its convenience. In the clothing and fashion industry though, there are still some elements that simply cannot replicate the brick-and-mortar experience, mainly trying on items. Perfitly attempts to solve this issue through AR/VR visualization. Users create a digital avatar based on two simple photos of themselves. The avatar can be used on any clothing brand’s site that teams with this startup. The technology uses 240,000 data points to make the avatar and clothing sizes as accurate as possible and a spokesperson said their clients have seen a reduction in item returns from 28 percent to 10.

Tompkins Robotics: Another impact of the e-commerce world is the need for extremely efficient and precise distribution centers. Tompkins Robotics is automating this process with its team of mobile item sorting devices for warehouses. According to the company, four of the United States’ 10 largest retailers have already partnered signed on to use the ‘automated robotic sortation’ devices.

https://www.instagram.com/p/BsqMaAZlTNz/

Locix: Also innovating in warehouse processes is Locix. The company uses image and machine learning to collect data on distribution center operations so retailers can better streamline workflow. Tools like an indoor GPS and HD motion sensors provide business analytics in real time.

The company uses image and machine learning to collect data on distribution center operations so retailers can better streamline workflow.

IAM Robotics: As a solution to the warehouse labor shortage, IAM robotics seeks to keep businesses efficient by automating the fulfillment operations for retailers. At the Innovation Lab, the company was showcasing its item-sorting robot that can be used both in the warehouse and storefront. Robotic devices were a major theme at this year’s show and IAM was among the most impressive.

https://www.instagram.com/p/BsqL_OwlGaW/

Onfleet: This last mile delivery solutions company is essentially doing for shipping what Uber has done for personal travel. Through its web dashboard, retail professionals can assign shipments to specific drivers based on convenience and other factors like who is nearest by and update them with real time maps. By sending the right driver at the right time on the right route, retailers can save time and deliver to customers efficiently.

Narrativ: Founded in 2015, this CNBC Top 100 Startup to watch is connecting brands with the content created about them online. The company lets businesses bid for publishers to link and mention them in their articles. This way, brands can gain exposure without creating an advertising strategy and drive sales to their site. Narrativ is already profitable and aims to help retailers win back customers from Amazon.

Trendalytics: Retailers, especially clothiers, are always trying to stay on top of the latest trends. Often, they are chasing trends that have already peaked in popularity however, or do not know whether the trend will be sustained. Trendalytics looks at data like Google search volume to identify trends and uncover their staying power in real time. With this new insight, brands can re-word existing product names to gain better traction on online searches and increase their visibility overall.

More NRF 2019!

With the first day of NRF under his belt, MarketScale’s Chief Digital Editor Geoff Short joined the podcast to provide an update of what he has seen so far. He marveled at the advancements in facial recognition technology, talked about his favorite booth so far, and provided an update on whether or not he has eaten one of those famous New York hot dogs.

For the latest news, videos, and podcasts in the Retail Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @RetailMKSL

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

GS
Geoff Short
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

Antibody developability checks are moving into discovery instead of waiting for development

Antibody developability checks are moving into discovery instead of waiting for development

Maria Gonzalez-Pajuelo of FairJourney Bio says the order in antibody discovery is changing: developability has become a much more important consideration during discovery, rather than an issue left until later-stage development. The goal, she says, is that what comes out of discovery is something CMC can take forward easily.

  • 01Discovery-stage developability screens can rank many antibodies tested once or twice and may reduce surprises later in development, while development still focuses on several lots of a single antibody and answers different questions.

Oct 1, 2026

Caraballo expects AI across all five tracks at ISPE’s 2026 Annual Meeting

Caraballo expects AI across all five tracks at ISPE’s 2026 Annual Meeting

ISPE’s 2026 Annual Meeting and Expo in Washington, DC organizes its program around five tracks running from discovery to governance, with international program committee chair Connie Langer of Pfizer Global Supply and executive chair Jose Caraballo of JCO Global Advisory LLC describing how the tracks connect—and why AI is treated as a cross-cutting topic rather than a standalone track. Deloitte’s December 2025 survey of 280 executives frames the mood the program is built for.

  • 01ISPE’s 2026 Annual Meeting has no dedicated AI track; executive chair Jose Caraballo expects AI presentations across all five tracks, from discovery to governance.
  • 02Deloitte’s December 2025 survey of 280 biopharma and medtech C-suite executives found more than 75% confident in their own outlook but only 41% optimistic about the global economy, a mood the story says the ISPE chairs are programming for.
  • 03A staffing firm reports life sciences job openings falling even as digital fluency becomes a required skill, so the upskilling burden lands on the people already employed, which is where the mandatory, university-partnered AI training Connie Langer describes at her company sits.

Sep 30, 2026

Crown Bioscience's San Diego site fits the tumor model to the therapy, not the reverse

Crown Bioscience's San Diego site fits the tumor model to the therapy, not the reverse

Crown Bioscience's San Diego site designs preclinical tumor models to match specific therapies and delivery routes, rather than forcing treatments into standard study designs. It combines custom surgical procedures, cell line-derived xenografts, patient-derived xenografts (including post-treatment models), and biomarker capabilities to generate translational data that can help sponsors decide whether to advance a program.

  • 01Orthotopic brain tumor implantation using tagged models lets researchers track tumor growth in the original organ, aligning the model and delivery route with how therapies are intended to be tested.
  • 02Patient-derived xenografts developed from tumors after prior treatment may better reflect progressed disease, helping teams study therapies aimed at patients whose cancer has advanced after earlier treatment.
  • 03Combining biomarker analysis of preclinical model samples with clinical sample testing at one site could make it easier to connect what is measured in animals with what is later measured in patients.

Sep 30, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

GS
Geoff Short

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512